aap Implantate AG (aap Implantate) is a medical device company. It provides trauma products and biomaterials for orthopedic treatment. The company products include locked plating systems for anatomical reduction, cannulated screws, standard plates and screws for osteosynthesis. Its orthopedic implants for trauma complementary biomaterials such as bone graft substitutes and bone replacement materials. The company produces plating systems for foot, shoulder, elbow, knee and ankle joints. The company offers its products to hospitals, purchasing syndicates and hospital groups. The company markets its products directly and through a network of distributors worldwide. aap Implantate is headquartered in Berlin, Germany.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company aap Implantate AG
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- aap Implantate AG Company Overview
- aap Implantate AG Company Snapshot
- aap Implantate AG Pipeline Products and Ongoing Clinical Trials Overview
- aap Implantate AG - Pipeline Analysis Overview
- aap Implantate AG - Key Facts
- aap Implantate AG - Major Products and Services
- aap Implantate AG Pipeline Products by Development Stage
- aap Implantate AG Ongoing Clinical Trials by Trial Status
- aap Implantate AG Pipeline Products Overview
- Loqteq Antibacterial Plate
- Loqteq Antibacterial Plate Product Overview
- Loqteq Antibacterial Plate Clinical Trial
- Loqteq VA Hook Plate 2.5
- Loqteq VA Hook Plate 2.5 Product Overview
- Loqteq VA L-Fusion Plate 2.5
- Loqteq VA L-Fusion Plate 2.5 Product Overview
- Loqteq VA Metatarsal L-Plate 2.5
- Loqteq VA Metatarsal L-Plate 2.5 Product Overview
- Loqteq VA Metatarsal Straight Plate 2.5
- Loqteq VA Metatarsal Straight Plate 2.5 Product Overview
- Loqteq VA Metatarsal T-Plate 2.5
- Loqteq VA Metatarsal T-Plate 2.5 Product Overview
- Loqteq VA MTP Fusion Plate 2.5
- Loqteq VA MTP Fusion Plate 2.5 Product Overview
- Loqteq VA MTP Revision Plate 2.5
- Loqteq VA MTP Revision Plate 2.5 Product Overview
- Loqteq VA Osteotomy Plate 2.5
- Loqteq VA Osteotomy Plate 2.5 Product Overview
- Loqteq VA Plantar Fusion Plate 2.5
- Loqteq VA Plantar Fusion Plate 2.5 Product Overview
- LOQTEQ VA Resorbable - Pin
- LOQTEQ VA Resorbable - Pin Product Overview
- LOQTEQ VA Resorbable - Plate
- LOQTEQ VA Resorbable - Plate Product Overview
- LOQTEQ VA Resorbable - Screw
- LOQTEQ VA Resorbable - Screw Product Overview
- Loqteq VA Straight Fusion Plate 2.5
- Loqteq VA Straight Fusion Plate 2.5 Product Overview
- Loqteq VA Tibia Plates
- Loqteq VA Tibia Plates Product Overview
- Loqteq VA X-Plate 2.5
- Loqteq VA X-Plate 2.5 Product Overview
- PMMA (Polymethylmethacrylate) Augmented LOQTEQ
- PMMA (Polymethylmethacrylate) Augmented LOQTEQ Product Overview
- Vertolast
- Vertolast Product Overview
- aap Implantate AG - Key Competitors
- aap Implantate AG - Key Employees
- aap Implantate AG - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- aap Implantate AG, Recent Developments
- Jun 13, 2023: AAP Implantate Executive Board proposes in the invitation to the Annual General Meeting various capital measures for resolution
- Jan 28, 2020: aap Implantate AG: FY/19: Good fourth quarter with EUR 3.1 million revenue (+17%) results in 9% revenue growth in fiscal year 2019 - Milestones in key technologies silver coating and magnesium-based implants
- Nov 19, 2019: aap receives further funding of up to EUR 2.7 million for its innovative antibacterial silver coating technology
- Nov 14, 2019: aap: Solid Q3/2019 with sales and EBITDA in line with expectations; sales growth and improved Recurring EBITDA in 9M/2019
- Aug 21, 2019: aap receives US-American clearance (FDA) for polyaxial LOQTEQ VA calcaneus system; market launch planned for beginning of 2020
- Aug 14, 2019: aap: Q2/2019 sales and EBITDA in line with guidance; double-digit sales growth in H1/2019
- Aug 08, 2019: aap receives BfArM approval for human clinical study and become global bellwether in antibacterial coating for trauma implants
- Jul 22, 2019: aap is granted European patent for its innovative resorbable magnesium implant technology
- Jul 12, 2019: aap receives US-American approval (FDA) for polyaxial LOQTEQ(R) VA foot system; market launch planned for beginning of 2020
- Jul 09, 2019: aap will discontinue parts of its standard trauma business at the end of FY/2019 within a cost reduction and efficiency enhancement program
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- aap Implantate AG Pipeline Products and Ongoing Clinical Trials Overview
- aap Implantate AG Pipeline Products by Equipment Type
- aap Implantate AG Pipeline Products by Indication
- aap Implantate AG Ongoing Clinical Trials by Trial Status
- aap Implantate AG, Key Facts
- aap Implantate AG, Major Products and Services
- aap Implantate AG Number of Pipeline Products by Development Stage
- aap Implantate AG Pipeline Products Summary by Development Stage
- aap Implantate AG Ongoing Clinical Trials by Trial Status
- aap Implantate AG Ongoing Clinical Trials Summary
- Loqteq Antibacterial Plate - Product Status
- Loqteq Antibacterial Plate - Product Description
- Loqteq Antibacterial Plate - LOQTEQ® Antibacterial Pre-Market Study Randomized, Controlled, Subject-blinded, Multi-center Study of LOQTEQ® Antibacterial Locking Plates in Subjects With Fractures of the Distal Fibula (AO Type 4F3 Injuries)
- Loqteq Antibacterial Plate - Study to Evaluate the Efficacy of Antibacterial Silver Coating Anatomical Plates for Fracture Treatment
- Loqteq VA Hook Plate 2.5 - Product Status
- Loqteq VA Hook Plate 2.5 - Product Description
- Loqteq VA L-Fusion Plate 2.5 - Product Status
- Loqteq VA L-Fusion Plate 2.5 - Product Description
- Loqteq VA Metatarsal L-Plate 2.5 - Product Status
- Loqteq VA Metatarsal L-Plate 2.5 - Product Description
- Loqteq VA Metatarsal Straight Plate 2.5 - Product Status
- Loqteq VA Metatarsal Straight Plate 2.5 - Product Description
- Loqteq VA Metatarsal T-Plate 2.5 - Product Status
- Loqteq VA Metatarsal T-Plate 2.5 - Product Description
- Loqteq VA MTP Fusion Plate 2.5 - Product Status
- Loqteq VA MTP Fusion Plate 2.5 - Product Description
- Loqteq VA MTP Revision Plate 2.5 - Product Status
- Loqteq VA MTP Revision Plate 2.5 - Product Description
- Loqteq VA Osteotomy Plate 2.5 - Product Status
- Loqteq VA Osteotomy Plate 2.5 - Product Description
- Loqteq VA Plantar Fusion Plate 2.5 - Product Status
- Loqteq VA Plantar Fusion Plate 2.5 - Product Description
- LOQTEQ VA Resorbable - Pin - Product Status
- LOQTEQ VA Resorbable - Pin - Product Description
- LOQTEQ VA Resorbable - Plate - Product Status
- LOQTEQ VA Resorbable - Plate - Product Description
- LOQTEQ VA Resorbable - Screw - Product Status
- LOQTEQ VA Resorbable - Screw - Product Description
- Loqteq VA Straight Fusion Plate 2.5 - Product Status
- Loqteq VA Straight Fusion Plate 2.5 - Product Description
- Loqteq VA Tibia Plates - Product Status
- Loqteq VA Tibia Plates - Product Description
- Loqteq VA X-Plate 2.5 - Product Status
- Loqteq VA X-Plate 2.5 - Product Description
- PMMA (Polymethylmethacrylate) Augmented LOQTEQ - Product Status
- PMMA (Polymethylmethacrylate) Augmented LOQTEQ - Product Description
- Vertolast - Product Status
- Vertolast - Product Description
- aap Implantate AG, Key Employees
- aap Implantate AG, Subsidiaries
- Glossary
- aap Implantate AG Pipeline Products by Equipment Type
- aap Implantate AG Pipeline Products by Development Stage
- aap Implantate AG Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Ethicon US LLC
- B. Braun Melsungen AG
- Biofrontera AG
- Konigsee Implantate GmbH
- MeVis Medical Solutions AG
- Merete Medical GmbH
- Biotech GmbH
- DocCheck AG
